<DOC>
	<DOC>NCT00233571</DOC>
	<brief_summary>The purpose of the study is to assess the long-term safety and clinical efficacy of adalimumab in patients with rheumatoid arthritis</brief_summary>
	<brief_title>A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Completion of a previous D2E7 study Subject is in good health (Investigator discretion) with a recent stable medical history Former enrollment in this trial (DE018) Subject is considered by the investigator, for any reason, to be an unsuitable candidate for the study Female subject who is pregnant or breast feeding or considering becoming pregnant.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>